Exousia Bio LMMY
OTC LMMY
$0.02 +0.00 (+26.67%)
At close: Sep 2, 2026 · 4:00 PM EDT

Exousia Bio (LMMY) Revenue (2023 - 2024)

Exousia Bio (LMMY) posted Revenue of $3750.0 for Q3 2024, little changed sequentially from $3750.0 in Q2 2024.

Analysis

Exousia Bio (LMMY) Revenue (2023 - 2024) Analysis & Trends

Exousia Bio (LMMY) has 2 years of Revenue data on file, last reported at $3750.0 in Q3 2024.

  • Quarterly Revenue changed N/A year-over-year to $3750.0 in Q3 2024, while the trailing twelve-month figure through May 2025 was $3750.0 (down 67.39% YoY) and the FY2025 annual result came in at $3750.0, down 67.39% from the prior year.
  • Revenue held at $3750.0 in Q3 2024 per LMMY's latest filing, from $3750.0 in the prior quarter.
  • The five-year high for Revenue was $3875.0 in Q4 2023, with the low at $3750.0 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 New Oriental Education & Technology 94.30 Bn 91.56 Bn 812.22 Mn 1.53 Bn
2 Laureate Education 5.01 Bn 4.85 Bn 237.67 Mn 615.86 Mn
3 Graham Holdings 4.80 Bn 3.55 Bn 777.03 Mn 1.30 Bn
4 Covista 4.49 Bn 4.08 Bn 284.63 Mn 501.38 Mn
5 Grand Canyon Education 3.98 Bn 3.70 Bn 204.08 Mn 264.05 Mn
6 Stride 3.66 Bn 2.70 Bn 217.28 Mn 636.06 Mn
7 McGraw Hill 2.54 Bn 2.35 Bn 439.20 Mn 549.90 Mn
8 Perdoceo Education 2.08 Bn 772.00 Mn 162.46 Mn 213.36 Mn
9 TAL Education 1.93 Bn -755.67 Mn 227.32 Mn 429.56 Mn
10 Exousia Bio 368,824.87 368,824.87 -62,108.00 -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2024 3,750.00
May 31, 2024 3,750.00
Feb 29, 2024 3,875.00
Nov 30, 2023 3,875.00